Senior Manager, Congress/Peer-to-Peer Marketing

Marlborough, MA (Remote)

$159K/yr – $199K/yrSenior Level8+ years expFull time

That's a $40K range! Where you land depends on how well you negotiate. Start practicing →

Posted 23 hrs ago

Job Summary

Original Job Description

Spend 15 mins, increase your paycheck by $15,000

$15,000 more per year. $45,000 over a 3-year tenure. One practice session with AI. That's the best ROI of any 15 minutes you'll spend this year.

Get Started

Sumitomo Pharma America, Inc.

Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and CNS. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company.Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html

Marketing team
27
Employees
1.1K
Headquarters
Marlborough, Massachusetts, USA
Founded
2023

Traffic Signals

Monthly Visitors
21.1K
Monthly Google Ads Budget
$0.0
Traffic Source Mix
Search
45.9%
Direct
41.2%
Referral
8%
Social
2.9%
Paid
1.8%

Headcount Trend

Current headcount: ~1.1K

Recent News

WV News
Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
Dec 8, 2025
MarketScreener
Sumitomo Pharma : Posted Conference on Q2 FY2025 Financial Results
Nov 7, 2025
PR Newswire
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
Jul 30, 2025